FindTrial
Sign In

Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis

Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spodylitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05997108
Enrollment
70
Registered
2023-08-18
Start date
2023-08-01
Completion date
2024-02-01
Last updated
2023-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Brief summary

this study aims to determine the relatioships among the NLR ,PLR ,MLR ,red cell volume and platelet volume indices levels as biomarkers in ankylosing spondylitis.

Interventions

DIAGNOSTIC_TESTCBC

Platelet and red blood cell volume indices

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* PATIENT WITH DISEASE DURATION OF MORE THAN 6 MONTHS * AGE MORE THAN 18 YEARS

Exclusion criteria

* PATIENT WITH CARDIAC ,CEREBROVASCULAR AND HEMATOLOGIC DIEASE * PTIENT WITH HYPERTENSION ,DIABETES ,METABOLIS SYNDROMES AND OTHER AUTOIMMUNE RHEUMATIC DISEASES.

Design outcomes

Primary

MeasureTime frameDescription
platelet6 monthsplatelet cell volume indices
Red blood cell6 monthsred blood cell volume indices

Countries

Egypt

Contacts

Primary ContactMARGO G MOFEED, resident
MARGO-GERGES-POST@MED.SOHAG.EDU.EG01276496930
Backup ContactMOHAMMED A ESMAIL, assistant professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026